Tourette Disorder Clinical Trial
Official title:
A Randomized Waitlist-Controlled Pilot Trial of Online-Delivered Comprehensive Behavioral Intervention for Tics-Enhanced (CBIT-E)
The purpose of this pilot trial is to examine the preliminary efficacy of online-delivered Comprehensive Behavioral Intervention for Tics - Enhanced (CBIT-E). In the study, 30 children with persistent tic disorders (PTDs) will be recruited via information provided to patients of the Marquette University (MU) Tic Disorders Specialty Clinic (TDSC) and information conveyed via local medical health professionals, with the goal of randomizing 10 participants to each group. For those randomized to CBIT-E, treatment will be administered according to the standard CBIT manual, but there will be two modifications. CBIT typically consists of the implementation of strategies to help manage the environment related to tics and the implementation of an exercise to engage in when an individual feels the urge to tic. CBIT-E will include these same techniques, plus additional in-session and out of session practice of the exercises, called competing responses, that individuals use when they feel the urge to tic. Treatment will be delivered over Microsoft Teams, which is a secure video conferencing system. The therapist will administer treatment from a private room in the Marquette University Tic Disorder Specialty Clinic, while the parent and child will be at their home. Treatment will include a screening visit, baseline assessment, 11 weeks (9 sessions) of CBIT-E, a post treatment assessment, and a three-month follow up assessment. Further, starting after session 3, there will be four 15-minute practice periods scheduled each week between sessions. During these practice periods, the child and therapist will meet over Microsoft Teams and the therapist will administer an enhanced reward task. Children randomized to the waitlist control (WLC) will not receive treatment during the 11-week period. Instead, they will be placed on a waitlist to receive standard CBIT following the end of the study period. Participants in this group will complete a screening visit, baseline assessment, and a final assessment, which will occur approximately 11 weeks after baseline.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02582515 -
Augmentation of Brief Habit Reversal Training With D-cycloserine or Placebo
|
N/A | |
| Completed |
NCT02114905 -
Dissemination of Comprehensive Behavioral Intervention for Tics (CBIT) to Occupational Therapists: A Feasibility Study
|
N/A | |
| Completed |
NCT03564132 -
Evaluating the Efficacy and Safety of Yi-Gan San in Children and Adolescents With Tourette's Disorder
|
Phase 2 | |
| Recruiting |
NCT05615220 -
Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults
|
Phase 3 | |
| Completed |
NCT00416091 -
Neuropsychological Functioning Among Children With Tourret's Disorder and ADHD
|
N/A | |
| Completed |
NCT03042507 -
Psychosocial Intervention for Young Children With Chronic Tics
|
N/A | |
| Completed |
NCT02619084 -
Subthalamic Stimulation in Tourette's Syndrome
|
Phase 2 | |
| Not yet recruiting |
NCT05942716 -
Serotonin Control of Impulsivity in Tourette Disorder
|
Phase 2 | |
| Completed |
NCT01547000 -
Guanfacine in Children With Tic Disorders
|
Phase 4 |